- Home
- BLZE vs CERS Comparison
BLZE vs CERS Comparison
Compare BLZE & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- CERS
- Stock Information
- Founded
- BLZE 2007
- CERS 1991
- Country
- BLZE United States
- CERS United States
- Employees
- BLZE N/A
- CERS N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- CERS EDP Services
- Sector
- BLZE Technology
- CERS Technology
- Exchange
- BLZE Nasdaq
- CERS Nasdaq
- Market Cap
- BLZE 381.2M
- CERS 347.3M
- IPO Year
- BLZE 2021
- CERS 1997
- Fundamental
- Price
- BLZE $7.21
- CERS $1.65
- Analyst Decision
- BLZE Strong Buy
- CERS Buy
- Analyst Count
- BLZE 4
- CERS 3
- Target Price
- BLZE $11.50
- CERS $3.17
- AVG Volume (30 Days)
- BLZE 369.2K
- CERS 1.6M
- Earning Date
- BLZE 02-25-2025
- CERS 02-20-2025
- Dividend Yield
- BLZE N/A
- CERS N/A
- EPS Growth
- BLZE N/A
- CERS N/A
- EPS
- BLZE N/A
- CERS N/A
- Revenue
- BLZE $122,579,000.00
- CERS $180,270,000.00
- Revenue This Year
- BLZE $27.53
- CERS $15.95
- Revenue Next Year
- BLZE $14.73
- CERS $10.50
- P/E Ratio
- BLZE N/A
- CERS N/A
- Revenue Growth
- BLZE 27.41
- CERS 15.29
- 52 Week Low
- BLZE $4.91
- CERS $1.38
- 52 Week High
- BLZE $12.65
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- BLZE 58.03
- CERS 41.40
- Support Level
- BLZE $7.01
- CERS $1.64
- Resistance Level
- BLZE $7.83
- CERS $1.96
- Average True Range (ATR)
- BLZE 0.42
- CERS 0.11
- MACD
- BLZE 0.06
- CERS -0.02
- Stochastic Oscillator
- BLZE 70.19
- CERS 3.12
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.